An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A plus CHP) in the Frontline Treatment of Patients with CD30+Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant Savage, K. J., Horwitz, S. M., Advani, R. H., Christensen, J. H., Domingo-Domenech, E., Rossi, G., Morschhauser, F., Alpdogan, O., Suh, C., Tobinai, K., Shustov, A. R., Trneny, M., Yuen, S., Zinzani, P., Truemper, L., Illidge, T., O'Connor, O., Pro, B., Little, M., Bunn, V., Fenton, K., Manley, T., Iyer, S. P. AMER SOC HEMATOLOGY. 2019

View details for DOI 10.1182/blood-2019-122781

View details for Web of Science ID 000518218500567